MS Views and News Be empowered with MS views and news. To receive The MS BEACON e-Newsletter, CLICK HERE - -

Visit our MS learning channel on YouTube, which provides hundreds of MS educational videos presented by MS Experts from across the USA. Archived here: www.youtube.com/msviewsandnews -- Also please visit our Social media platforms: Facebook, Twitter, and Instagram . Each providing important information for the MS community. Furthermore, scroll down the left side of this blog to learn from the resources and links.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, for your personal knowledge and to keep you informed of current health-related issues. It is not a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~


Friday, November 13, 2009

Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching


By David Phillips | Nov 12, 2009

On November 2, Biogen Idec updated the prescribing label for its blockbuster multiple sclerosis drug Tysabri(natalizumab) after consultation with the FDA. Aside from acknowledging that the risk of developing progressive multifocal leukoencephalopathy (PML), an often fatal brain infection, increases with longer duration of treatment, no other revisions concerning the risk of PML were required. The fact that this biologic remains a cornerstone treatment for adult patients with relapsing forms of MS — only the second drug to ever return to U.S. pharmacy shelves after having been withdrawn — speaks volumes to the growing influence of the Web.

The Internet has radically changed pharmaceutical marketing and sales. No longer do drug companies need legions of attractive and personable salespeople to “detail” physicians on the efficacy and patient benefits of their choice drugs.

Continue

====================
Posted by: Stuart Schlossman of MS Views and News
Register at our website to be ensured that you will keep up to date with Multiple Sclerosis News and Information.
.
.
~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

No comments: